Phase 3 Peritoneal Dialysis Clinical Trials
5 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–5 of 5 trials
Recruiting
Phase 3
A Clinical Study of TS-172 in Hyperphosphatemia Patients on Peritoneal Dialysis
Hyperphosphatemia Patients on Peritoneal Dialysis
Taisho Pharmaceutical Co., Ltd.30 enrolled1 locationNCT07548853
Recruiting
Phase 3
Comparing High and Low Dose Iron Treatments for People on Peritoneal Dialysis: The PALaDIN Study
Iron deficiency anaemiaPeritoneal DialysisAnaemia
Hull University Teaching Hospitals NHS Trust30 enrolled1 locationNCT06884280
Recruiting
Phase 3
meChANisms and sAfety of SGLT2 Inhibition in peRitoneal dialYsis
Kidney DysfunctionEnd-stage Kidney DiseasePeritoneal Dialysis Complication+2 more
University Health Network, Toronto20 enrolled1 locationNCT05715814
Recruiting
Phase 3
Alirocumab in Patients on a Stable Dialysis Regimen
Peritoneal DialysisHemodialysisAtherosclerotic Disease+1 more
Baylor Research Institute20 enrolled1 locationNCT03480568
Completed
Phase 3
The Beta-blocker to LOwer CArdiovascular Dialysis Events (BLOCADE) Feasibility Study
end-stage kidney disease
haemodialysis
peritoneal dialysis
Australasian Kidney Trials Network- University of Queensland150 enrolled10 locationsACTRN12609000174280